Decision: Favourable

Study Title:

A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients with Dedifferentiated Liposarcoma

  • NREC Code:

    21-NREC-CT-084

  • Decision:

    Favourable

  • Meeting Date:

    22/09/2021

  • Study Type:

    CT application

  • Principal Investigator:

    Professor Mark Doherty

  • PI Institution:

    St Vincent's University Hospital

  • Sponsor:

    PSI CRO

Scroll to Top